Evolving Perspectives in Endometrial Cancer: Addressing Unmet Needs and Treatment Sequencing in Clinical Practice

Learning Objectives

  • Assess the current and evolving treatment landscape of advanced and recurrent endometrial cancer, including key challenges and unmet needs 
  • Explore the role of molecular subtypes and biomarkers in optimizing patient selection and informing treatment sequencing 
  • Examine personalized treatment approaches in endometrial cancer through analysis of real-world case scenarios 

Moderator

Helen MacKay, MD

Sunnybrook Odette Cancer Center

Speakers

Domenica (Ketta) Lorusso, MD, PhD

Humanitas University, Pieve Emanuele, Humanitas San Pio X Hospital

Kosei Hasegawa, MD, PhD

Saitama Medical University

Agenda

12:45 – 12:49
Welcome

Helen MacKay, MD

12:49 – 13:00
Endometrial Cancer: Current and Evolving Treatment Landscape

Domenica Lorusso, MD, PhD

13:00 – 13:25
Biomarker Considerations and Immunotherapy Sequencing

Kosei Hasegawa, MD, PhD

13:25 – 13:50
Personalized Treatment Approaches and Case-Based Discussions

Helen MacKay, MD

13:50 – 13:55
Meeting Conclusion

Helen MacKay, MD